Literature DB >> 15117924

Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.

Young Uh1, Dong Hoon Shin, In Ho Jang, Gyu Yel Hwang, Mi Kyung Lee, Kap Jun Yoon, Hyo Youl Kim.   

Abstract

OBJECTIVES: Our aim was to study the antimicrobial susceptibilities and macrolide resistance mechanisms of viridans group streptococci (VGS) in a Korean tertiary hospital.
METHODS: MICs of five antimicrobials were determined for 106 VGS isolated from blood cultures. The macrolide resistance mechanisms of erythromycin non-susceptible isolates were studied by the double-disc test and PCR.
RESULTS: In all, 42.4% of the isolates were susceptible to penicillin. Nine of 61 penicillin non-susceptible isolates were fully resistant (MIC >/= 4 mg/L). Rates of non-susceptibility to erythromycin, clindamycin and ceftriaxone were 33.9%, 17.9% and 9.4%, respectively. Twenty-two (61.1%) of 36 erythromycin non-susceptible isolates expressed constitutive resistance to macrolide-lincosamide-streptogramin B antibiotics (a constitutive MLS(B) phenotype); 13 isolates (36.1%) expressed an M phenotype; and one isolate, a Streptococcus bovis isolate, had an inducible MLS(B) resistance phenotype. erm(B) was found in isolates with constitutive/inducible MLS(B) phenotypes, and mef(A) in isolates with the M phenotype. In three isolates (two isolates with a constitutive MLS(B) phenotype and in one isolate with the M phenotype), none of erm(A), erm(B), erm(C) or mef(A) was detected by PCR.
CONCLUSIONS: Penicillin non-susceptible VGS were more resistant to erythromycin, clindamycin and ceftriaxone than were penicillin-susceptible isolates. A constitutive MLS(B) phenotype associated with erm(B) was the predominant mechanism of macrolide resistance among erythromycin non-susceptible isolates from this Korean hospital.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117924     DOI: 10.1093/jac/dkh219

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Comparing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Phenotypic and Molecular Methods for Identification of Species within the Streptococcus anginosus Group.

Authors:  Raquel Arinto-Garcia; Marcos Daniel Pinho; João André Carriço; José Melo-Cristino; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

2.  [S2 Guideline for diagnosis and therapy of infectious endocarditis].

Authors:  C K Naber
Journal:  Z Kardiol       Date:  2004-12

3.  Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.

Authors:  Ronda L Akins; Bradley D Katz; Catherine Monahan; Dylan Alexander
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

4.  In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.

Authors:  Iciar Rodríguez-Avial; Carmen Rodríguez-Avial; Esther Culebras; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis.

Authors:  Keigo Maeda; Yuzo Hirai; Masanori Nashi; Shinsuke Yamamoto; Naoki Taniike; Toshihiko Takenobu
Journal:  J Dent Sci       Date:  2021-09-28       Impact factor: 3.719

6.  Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital.

Authors:  Young Uh; Gyu Yel Hwang; In Ho Jang; Ohgun Kwon; Hyo Youl Kim; Kap Jun Yoon
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

7.  Gingival crevicular fluid biomarkers in type 1 diabetes mellitus: A case-control study.

Authors:  Maria Sereti; Margaux Roy; Alkisti Zekeridou; Giacomo Gastaldi; Catherine Giannopoulou
Journal:  Clin Exp Dent Res       Date:  2020-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.